title: Myriad Genetics: In the eye of the policy storm.
abstract: From the late 1980s, a storm surrounding the wisdom, ethics, and economics of human gene patents has been brewing. The various winds of concern in this storm touched on the impact of gene patents on basic and clinical research, on health care delivery, and on the ability of public health care systems to provide equal access when faced with costly patented genetic diagnostic tests. Myriad Genetics, Inc., along with its subsidiary, Myriad Genetic Laboratories, Inc., a small Utah-based biotechnology company, found itself unwittingly in the eye of this storm after a series of decisions it made regarding the commercialization of a hereditary breast cancer diagnostic test. This case study examine the background to Myriad's decisions, the context in which these decisions were made and the policy, research and business response to them.
authors.affiliation: McGill Faculty of Law, McGill University, 3644 Peel Street, Montreal, Quebec, Canada. richard.gold2@mcgill.ca
authors.forename: E Richard
authors.initials: ER
authors.lastname: Gold
authors.forename: Julia
authors.initials: J
authors.lastname: Carbone
mesh_terms: D001709:Biotechnology; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics*; D003132:Commerce / Q000191:economics / Q000941:ethics; D005260:Female; D005796:Genes; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing / Q000941:ethics*; D005823:Genetics; D006291:Health Policy; D006297:Health Services Accessibility / Q000191:economics / Q000941:ethics*; D006801:Humans; D007753:Laboratories; D010330:Patents as Topic / Q000941:ethics*; D011933:Reagent Kits, Diagnostic; D014589:Utah
chemical_list: D011933:Reagent Kits, Diagnostic
references.citation: Cancer Genet Cytogenet. 2006 Mar;165(2):91-7
references.pmid: 16527602
references.citation: JAMA. 2006 Mar 22;295(12):1379-88
references.pmid: 16551709
references.citation: Soc Sci Med. 2008 Jul;67(1):152-60
references.pmid: 18436360
references.citation: Nat Genet. 2001 Sep;29(1):15-6
references.pmid: 11528382
references.citation: McGill Law J. 2000 May;45(2):437-60
references.pmid: 12688281
references.citation: J Mol Diagn. 2003 Feb;5(1):3-8
references.pmid: 12552073
references.citation: Eur J Hum Genet. 2002 Dec;10(12):783-5
references.pmid: 12461683
references.citation: Nat Biotechnol. 2006 Sep;24(9):1091-4
references.pmid: 16964215
references.citation: J Clin Oncol. 1996 May;14(5):1730-6; discussion 1737-40
references.pmid: 8622094
references.citation: BMC Med Ethics. 2008 Feb 22;9:4
references.pmid: 18294373
references.citation: New Genet Soc. 2003 Dec;22(3):271-96
references.pmid: 15115034
references.citation: Community Genet. 2005;8(4):228-34
references.pmid: 16244477
references.citation: Genet Med. 2005 May-Jun;7(5):311-6
references.pmid: 15915082
references.citation: JAMA. 2002 Oct 9;288(14):1762-7
references.pmid: 12365961
references.citation: Health Law J. 2002;10:123-46
references.pmid: 14748275
references.citation: J Natl Cancer Inst. 2003 Jan 1;95(1):8-9
references.pmid: 12509391
references.citation: Science. 2004 Mar 19;303(5665):1757-8
references.pmid: 15031474
references.citation: Science. 1997 Dec 12;278(5345):1874
references.pmid: 9417630
references.citation: Cancer Res. 1999 Jan 15;59(2):455-61
references.pmid: 9927062
references.citation: Am J Manag Care. 2005 Oct;11(10):601-8
references.pmid: 16232001
references.citation: J Clin Oncol. 2002 Nov 15;20(22):4485-92
references.pmid: 12431973
references.citation: N Engl J Med. 2006 Aug 10;355(6):543-5
references.pmid: 16899772
references.citation: Gynecol Oncol. 2003 Jan;88(1 Pt 2):S8-10; discussion S11-3
references.pmid: 12586076
references.citation: Lancet. 1991 Jul 13;338(8759):82-3
references.pmid: 1676470
references.citation: J Child Fam Nurs. 1999 Sep-Oct;2(5):388-90
references.pmid: 10795196
references.citation: Clin Invest Med. 2001 Jun;24(3):147-57
references.pmid: 11437066
references.citation: Soc Stud Sci. 2005 Feb;35(1):5-40
references.pmid: 15991444
references.citation: Nature. 2000 Oct 26;407(6807):934
references.pmid: 11069152
references.citation: Clin Genet. 2004 Oct;66(4):311-7
references.pmid: 15355433
references.citation: J Natl Cancer Inst. 2000 Apr 19;92(8):596
references.pmid: 10772669
references.citation: J Med Genet. 2002 Nov;39(11):817-21
references.pmid: 12414821
references.citation: Kennedy Inst Ethics J. 2006 Jun;16(2):105-28
references.pmid: 17036443
references.citation: Science. 1998 May 1;280(5364):698-701
references.pmid: 9563938
references.citation: MedGenMed. 2005 Jun 29;7(2):60
references.pmid: 16369438
references.citation: Nature. 2002 Feb 7;415(6872):577-9
references.pmid: 11832913
references.citation: Nature. 1995 Dec 21-28;378(6559):789-92
references.pmid: 8524414
references.citation: West J Med. 2001 Sep;175(3):168-73
references.pmid: 11527843
references.citation: MMWR Morb Mortal Wkly Rep. 2004 Jul 16;53(27):603-6
references.pmid: 15254451
references.citation: Int J Cancer. 2006 May 1;118(9):2281-4
references.pmid: 16331614
references.citation: South Calif Interdiscip Law J. 1996 Winter;5(1):25-40
references.pmid: 16211765
references.citation: Public Aff Q. 2004 Oct;18(4):299-344
references.pmid: 15812959
references.citation: Rev Am Hist. 2002 Mar;30(1):114-23
references.pmid: 11949674
references.citation: Am J Hum Genet. 1993 Apr;52(4):678-701
references.pmid: 8460634
references.citation: Nat Biotechnol. 2000 Aug;18(8):820
references.pmid: 10932143
references.citation: Soc Sci Med. 2000 Sep;51(6):821-9
references.pmid: 10972427
references.citation: Health Law J. 1999;7:69-90
references.pmid: 11066370
references.citation: Nat Genet. 1996 Mar;12(3):333-7
references.pmid: 8589730
references.citation: Lancet Oncol. 2005 May;6(5):301-10
references.pmid: 15863378
references.citation: Am J Hum Genet. 1991 Feb;48(2):232-42
references.pmid: 1990835
references.citation: EMBO Rep. 2002 Dec;3(12):1120-2
references.pmid: 12475923
references.citation: Kennedy Inst Ethics J. 2006 Mar;16(1):1-37
references.pmid: 16770885
references.citation: Am J Med Genet. 1999 Mar 19;83(3):157-63
references.pmid: 10096590
references.citation: Eubios J Asian Int Bioeth. 2003 Mar;13(2):57-9
references.pmid: 17117541
references.citation: Health Aff (Millwood). 2006 Jul-Aug;25(4):911-22
references.pmid: 16835169
references.citation: Aust New Zealand Health Policy. 2006 Nov 08;3:13
references.pmid: 17092338
references.citation: Nat Biotechnol. 2006 Jan;24(1):31-9
references.pmid: 16404390
references.citation: Am J Hum Genet. 1992 Mar;50(3):476-82
references.pmid: 1539589
references.citation: Community Genet. 2005;8(4):235-42
references.pmid: 16244478
references.citation: Eur J Hum Genet. 2002 Oct;10(10):599-606
references.pmid: 12357330
references.citation: Science. 1994 Oct 7;266(5182):66-71
references.pmid: 7545954
references.citation: Prev Med. 2002 Jun;34(6):590-5
references.pmid: 12052018
references.citation: Genet Med. 2007 Dec;9(12):850-5
references.pmid: 18091435
references.citation: Science. 1994 Sep 30;265(5181):2088-90
references.pmid: 8091231
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):79-87
references.pmid: 11815404
references.citation: Nature. 2003 May 8;423(6936):105
references.pmid: 12736643
references.citation: Science. 1990 Dec 21;250(4988):1684-9
references.pmid: 2270482
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2397-406
references.pmid: 12692171
references.citation: Nat Rev Genet. 2002 Oct;3(10):803-8
references.pmid: 12360238
references.citation: Eur J Cancer Care (Engl). 1998 Sep;7(3):174-80
references.pmid: 9793009